Laëtitia Vercellino

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

Laëtitia Vercellino, Roberta Di Blasi, Salim Kanoun et al. · Blood Advances · 2020 · 404 citations · Full text

Medicine, Oncology, Cell Therapy +16

Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer

David Groheux, Sylvie Giacchetti, Jean‐Luc Moretti et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 399 citations

Medicine, Nuclear Medicine, Oncology +14

The full spectrum of Castleman disease: 273 patients studied over 20 years

Éric Oksenhendler, David Boutboul, David C. Fajgenbaum et al. · British Journal of Haematology · 2017 · 205 citations

Medicine, Oncology, Pathology +12

Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT†

Anne‐Ségolène Cottereau, Michel Meignan, Christophe Nioche et al. · Annals of Oncology · 2020 · 201 citations · Full text

Medicine, Oncology, Radiology +13

High total metabolic tumor volume at baseline predicts survival independent of response to therapy

Laëtitia Vercellino, Anne‐Ségolène Cottereau, Olivier Casasnovas et al. · Blood · 2020 · 185 citations · Full text

Medicine, Cancer Biology, Oncology +12